How is the Pharvaris NV today?

The Pharvaris NV today is trading in the down by -0.72% at 16.60.

How has Pharvaris NV performed historically?

The Pharvaris NV is currently trading down -0.72% on an intraday basis in the past week the index rose 3.81%. The index has been up 4.40% in the past quarter and fell -12.45% in the past year. You can view this in the overview section.

What is Pharvaris NV Annual Net Profit?

Pharvaris NV Annual Net Profit fell 33.06% in the last year to $134.22 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Pharvaris NV Price to Earning Ratio?

Pharvaris NV Price to Earning Ratio is -5.22, which is negative.

What is Pharvaris NV Stock Price?

Pharvaris NV Stock Price fell 12.45% and underperformed its sector by 67.92% in the past year.

What is Pharvaris NV Quarterly Net profit?

Pharvaris NV Quarterly Net profit fell 65.39% YoY to $46.34 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Pharvaris NV Debt to Equity Ratio?

Pharvaris NV Debt to Equity Ratio is zero as the company is debt-free.

What is Pharvaris NV Return on Equity(ROE)?

Pharvaris NV Return on Equity(ROE) for the last financial year was -41.18%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Pharvaris NV Mutual Fund Holding?

Pharvaris NV Mutual Fund Holding decreased by 0.06% in the last quarter to 10.5.

Pharvaris NV XNAS: PHVS

Pharvaris NV Live Share Price Today, Share Analysis and Chart

Name: Pharvaris NV: Is Infosys Ltd. worth buying?
Item: Pharvaris NV
Rating: 1.12150
Author: Trendlyne DVM scores

about

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules,...

16.60 -0.12 (-0.72%)

34.90% Fall from 52W High

189.8K XNAS Volume

High volume today

XNAS 30 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Pharvaris NV is on 11 Jun 2025 for the purpose of 46th Annual Goldman Sachs Global Healthcare Conference See details

Not Eligible

Expensive Valuation

6.5 / 100

Technically Neutral

38.4 / 100

No estimates available

Pharvaris NV Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Pharvaris NV Live Share Price Today, Share Analysis and Chart

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules,...

34.90% Fall from 52W High

High volume today

Pharvaris NV Live Price Chart

Pharvaris NV FAQ

How is Pharvaris NV today?

Pharvaris NV today is trading in the red, and is down by -0.72% at 16.60.

How has Pharvaris NV performed historically?

Pharvaris NV is currently trading down -0.72% on an intraday basis. In the past week the stock rose 3.81%. stock has been up 4.40% in the past quarter and fell -12.45% in the past year. You can view this in the overview section.